Patients with DM2 exhibit abnormalities in tissue sensitivity to insulin, as well as insulin secretion, by the pancreas, as pancreatic beta cells adapt to changes in insulin action (decreased insulin action means increased insulin secretion and vice versa). Here, INS is linked to myotonic dystrophy type 2.